A potent interferon inducer, synthetic polyinosinic acid-polycytidylic acid complex (poly I:C), was used prophylactically and therapeutically in experimental ocular Toxoplasma infections in rabbits. Daily intravenous injections of poly I:C alone or when combined with daily subconjunctival injections of the inducer delayed the appearance of conjunctivitis, corneal opacity, and iritis in Toxoplasma-infected eyes provided that the treatment was started 1 day before the infection. When the treatment was begun at the same time or 1 day after the infection, no delay in the production of the ocular lesions was noted. In no case was the treatment curative or completely suppressive.
In 1968, Remington and Merigan (9) reported that chick and mouse cell monolayers treated with virus-induced interferon (IF) were significantly protected from destruction by the RH strain of Toxoplasma gondii. Recently, the same authors noted that treatment of mice with an IF-inducer, pyran, also decreased mortality and prolonged life of mice infected with the C56 strain of Toxoplasma organisms (10) .
A synthetic polyinosinic acid-polycytidylic acid complex (poly I:C) has been shown to be a potent IF Evaluation of ocular lesions. Each day during the first week and every other day thereafter, the eyes were examined for signs of conjunctivitis, corneal opacity, and iritis. No attempts were made to grade the severity of these lesions since the lesions progressed rapidly to maximum severity once they appeared, regardless of the treatment.
Detection of IF in serum and aqueous humor. Serum was separated from clotted blood that had been collected aseptically from an ear vein. Aqueous humor was collected from both eyes of each rabbit and pooled. Aqueous humor specimens showing gross contamination with blood cells were discarded. The As shown in Fig. 1 , an inoculum of 105 MLD50 of the organisms produced conjunctivitis, corneal opacity, and iritis in all eyes as early as 1 day after infection, and the lesions became progressively worse thereafter. In the eyes inoculated with 103 MLD50 of the organisms, signs of conjunctivitis and iritis bzgan to appear in 20%o of the eyes on day 2 and in all eyes on day 3. The corneal opacity, however, did not appear until day 5. With 10 MLD50, conjunctivitis and iritis were first noted in few eyes on day 5 and in all eyes on day 6. Corneal opacity was apparent in 50 % of the eyes on day 7 and in all eyes on day 10. Heatinactivated Toxoplasma organisms did not produce the ocular lesions. On this basis, it was decided then that 103 MLD50 of the organisms would be used consistently in the subsequent experiments.
Effect of daily intravenous injections of poly I:C on Toxoplasma lesions. Three groups of six rabbits each received daily intravenous (iv) injections of 0.5 mg of poly I:C for 8 days. The injections of poly I:C were started 1 day before infection, on the day of infection, or 1 day after intraocular inoculation of 103 MLD50 of T. gondii, respectively. Another group of six rabbits served as a control series and received daily iv injections of PBS starting 1 day before the Toxoplasma inoculation.
As shown in Fig. 2 , conjunctivitis and iritis began to appear as early as day 1 in a few eyes, and almost all eyes were affected by day 4 in the control group. In contradistinction to these findings, the group which received daily poly I:C injections beginning 1 day before infection showed no sign of conjunctivitis or iritis up to day 4. However, all eyes of the animals in this group showed the classical signs of infection by day 10. When daily iv injections of poly I :C were initiated at the same time or 1 day after the Toxoplasma injection, no significant delaying effect was noted in the production of corneal opacity or iritis, although a slight delay in the appearance of conjunctivitis was noted. Poly I:C treatment had no deterrent effect on the death rate of Toxoplasma-infected rabbits. All rabbits of the treated as well as the control groups died of widely disseminated toxoplasmosis 2 to 4 weeks after infection.
Induction of IF in blood and aqueous humor by daily iv injections of poly I:C. The kinetics of IF induction in blood and aqueous humor after daily iv injections of poly I:C was studied. Blood was collected from five rabbits at 3, 6, and 24 hr after each iv injection of 0.5 mg of poly I:C. Aqueous humor was also collected from them 3 hr after poly I:C injection on days 0, 2, and 4.
As shown in Fig. 3 , the levels of IF in both serum and aqueous humor were highest 3 hr after the first iv injection of poly I: C, but the levels declined rapidly thereafter, and no IF was detected at 24 hr. Each subsequent daily iv injection of the same amount of poly I: C induced a high titer of IF in both serum and aqueous humor, but on each succeeding day a lesser amount was produced than on the preceding day, and very low titers (essentially no IF) were detected in either the serum or the aqueous humor from day 4 onward.
Effect of daily iv and subconjunctival injections of poly I: C on ocular toxoplasmosis. In the foregoing experiments, daily iv injections of poly I:C delayed the appearance of the ocular lesions but did not prevent the infection. The treatment was ineffective if it was started either on the same day or 1 day after the infection. This limited effectiveness of poly I:C could be due to the brevity of the presence of IF in the ocular sites (Fig. 3) . Therefore, it was thought that daily iv injections of poly I:C in combination with daily subconjunctival injections of poly I :C might maintain higher levels of IF in the ocular tissues for longer periods. This combination, it was thought, might provide more effective protection. When daily iv (0.5 mg) and subconjunctival (0.1 mg) injections of pity I:C were initiated 1 day before Toxoplasma inoculation, the production of the ocular lesions was delayed 2 to 3 days, as compared to the control rabbits, but all eyes showed signs of infection between days 6 and 8. If the treatment was started 1 day after infection, it was definitely less effective. Daily subconjunctival injections of 0.1 mg of poly I:C alone resulted in a mild transient conjunctivitis.
DISCUSSION
The present study showed that daily iv injections of poly I:C delayed the production of ocular lesions by the RH strain of T. gondii provided the treatment was started 1 (11) has shown that "accessory factor," a complement-like substance believed to be identical to properidin, is essential for the immunoinactivation of Toxoplasma. It remains to be seen whether any of these mechanisms is responsible for the observed effect of poly I:C on experimental Toxoplasma infections in rabbit eyes.
